Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Cancer Cell|October 14, 2015
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human CancersXiaohui Yan, Zhongyi Hu, Yi Feng, et al.
Genome Biology|May 13, 2015
Erratum to: Modeling precision treatment of breast cancerAnneleen Daemen, Obi L Griffith, Laura M Heiser, et al.
Genome Biology|November 2, 2013
Modeling precision treatment of breast cancerAnneleen Daemen, Obi L Griffith, Laura M Heiser, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Cancer Discovery|April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersVivian W Y Lui, Matthew L Hedberg, Hua Li, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Cancer Cell|October 14, 2015
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human CancersXiaohui Yan, Zhongyi Hu, Yi Feng, et al.
Genome Biology|May 13, 2015
Erratum to: Modeling precision treatment of breast cancerAnneleen Daemen, Obi L Griffith, Laura M Heiser, et al.
Genome Biology|November 2, 2013
Modeling precision treatment of breast cancerAnneleen Daemen, Obi L Griffith, Laura M Heiser, et al.
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Cancer Discovery|April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersVivian W Y Lui, Matthew L Hedberg, Hua Li, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|December 22, 2018
Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Pageof 23